A
Addex Therapeutics Ltd (ADXN)
NCM – Real vaqt narxi. Valyuta: USD
6.07
+0.13 (2.19%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
6.07
+0.13 (2.19%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
Addex Therapeutics Ltd Shveytsariyada nevrologik kasalliklar uchun kichik molekulali farmatsevtika mahsulotlarini ishlab chiqaradi, rivojlantiradi va tijoratlashtiradi. Kompaniya G-protein bilan bog'langan retseptorlar va fermentlarni kashf qilishga qaratilgan. Uning asosiy dasturlari orasida Dipraglurant mavjud bo'lib, u insultdan keyingi/bosh miya jarohatidan tuzalishni davolash, shuningdek, Parkinson kasalligining levodopa bilan bog'liq diskineziyasini davolash uchun 1-bosqich klinik sinovdan o'tmoqda. Kompaniya, shuningdek, ADX71149ni ishlab chiqmoqda, u aniqlanmagan ko'rsatma uchun 1-bosqichda; va og'riq, xavotir, qaramlik, surunkali yo'tal va giperaktiv siydik pufagini davolash uchun GABAB PAM. Uning inson salomatligini davolash uchun mGlu2 PAM birikmalarini ishlab chiqish bo'yicha Janssen Pharmaceuticals Inc. bilan litsenziya va hamkorlik shartnomasi; va qaramlik va boshqa O'MS kasalliklarini davolash uchun yangi GABAB PAM birikmalarini kashf qilish, ishlab chiqish va tijoratlashtirish bo'yicha Indivior PLC bilan litsenziya va tadqiqot shartnomasi mavjud. Kompaniya ilgari Addex Pharmaceuticals Ltd nomi bilan tanilgan. Addex Therapeutics Ltd 2002 yilda tashkil etilgan va Jeneva, Shveytsariyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mikhail Kalinichev Ph.D. | Head of Translational Science |
| Dr. Roger G. Mills M.D. | Chief Medical Officer & Director |
| Mr. Lénaic Teyssédou | Head of Finance |
| Mr. Timothy Mark Dyer | Co-Founder, CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-25 | 6-K | tm2618934d1_6k.htm |
| 2026-06-05 | 6-K | f6k_060526.htm |
| 2026-05-15 | 20-F | adxn-20251231x20f.htm |
| 2026-04-29 | 6-K | f6k_042926.htm |
| 2026-04-23 | 6-K | f6k_042326.htm |
| 2026-04-21 | 6-K | f6k_042126.htm |
| 2026-02-03 | 6-K | f6k_020326.htm |
| 2026-01-07 | 6-K | f6k_010726.htm |
| 2025-12-10 | 6-K | tm2531595d5_6k.htm |
| 2025-12-04 | 6-K | tm2532672d1_6k.htm |